ACCES TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) FOR INJECTING DRUG USERS IN THE WHO EUROPEAN REGION 2002-2004
Saved in:
DONOGHOE, M.C., ET AL., ACCES TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) FOR INJECTING DRUG USERS IN THE WHO EUROPEAN REGION 2002-2004. INTERNATIONAL JOURNAL OF DRUG POLICY, THE, Vol. 18, no. 4 (2007), p. 271-280.
Ref.
157724
Sted:
SIIS R.1114 Archivo
Palabras clave:
Acceso, Discapacidad, Drogas ilegales, Drogodependencias, Estudio comparativo, Sida, Tratamiento médico, Utilización de servicios, Vía intravenosa, Europa
Acceso, Discapacidad, Drogas ilegales, Drogodependencias, Estudio comparativo, Sida, Tratamiento médico, Utilización de servicios, Vía intravenosa, Europa
Lignende værker: ACCES TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) FOR INJECTING DRUG USERS IN THE WHO EUROPEAN REGION 2002-2004
- WITHDRAWAL SYMPTOMS AS A PREDICTOR OF MORTALITY IN PATIENTS HIV-INFECTED THROUGH DRUG USE AND RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)
- THE IMPACT OF METHADONE OR BUPRENORPHINE TREATMENT AND ONGOING INJECTION ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) ADHERENCE: EVIDENCE FROM THE MANIF2000 COHORT STUDY
- SOCIAL AND STRUCTURAL DETERMINANTS OF HAART ACCESS AND ADHERENCE AMONG INJECTION DRUG USERS
- METHADONE MAINTENANCE THERAPY PROMOTES INITIATION OF ANTIRETROVIRAL THERAPY AMONG INJECTION DRUG USERS
- IMPACT OF HIV TESTING ON UPTAKE OF HIV THERAPY AMONG ANTIRETROVIRAL NAIVE HIV. INFECTED INJECTION DRUG USERS
- DOES INITIATION OF HIV ANTIRETROVIRAL THERAPY INFLUENCE PATTERNS OF SYRINGE LENDING AMONG INJECTION DRUG USERS?